During the past decade, Eye Care Associates of Nevada conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Eye Care Associates of Nevada" are "Blepharitis" (1 trials) and "Dry Eye Disease (DED)" (1 trials). Many other conditions were trialed in "Eye Care Associates of Nevada" in a lesser frequency.

Most popular intervention types in "Eye Care Associates of Nevada" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "011516X (New Artificial Tear Formulation)" (1 trials), "Azasite" (1 trials), "Dexamethasone" (1 trials), "ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined)" (1 trials) and "REFRESH PLUS®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eye Care Associates of Nevada" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Eye Care Associates of Nevada". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Eye Care Associates of Nevada, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eye Care Associates of Nevada, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".